|
|
|
|
|
Evaluation of transurethal alprostadil for safety and efficacy in men with erectile dysfunction |
2545 |
# |
|
|
|
|
|
Evaluation of tumorigenic potential of CeO(2) and Fe(2)O(3) engineered nanoparticles by a human cell in vitro screening model. |
2560 |
# |
|
|
|
|
|
Evaluation of Ultrafast Wave?Controlled Aliasing in Parallel Imaging 3D-FLAIR in the Visualization and Volumetric Estimation of Cerebral White Matter Lesions |
2564 |
# |
|
|
|
|
|
Evaluation of window parameters of Noncontrast cranial ct brain images for Hyperacute and acute ischemic stroke classification with deep learning |
2564 |
# |
|
|
|
|
|
Evaluation, Diagnosis, and Treatment of Gastrointestinal Disorders in Individuals With ASDs: A Consensus Report |
2553 |
# |
|
|
|
|
|
Event free survival at 24 months is a strong surrogate prognostic endpoint of peripheral T cell lymphoma |
2562 |
# |
|
|
|
|
|
Event-free survival at 12 months is a strong surrogate endpoint for stage 1 diffuse large B cell lymphoma: a report from Nation Wide Registry Thai Lymphoma Study Group |
2563 |
# |
|
|
|
|
|
Everolimus (EVE) plus letrozole (LET) in patients (pts) with estrogen receptor-positive (ER plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Progression-free survival (PFS) subgroup analyses in BOLERO-4 |
2560 |
# |
|
|
|
|
|
Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Clinical Trial. |
2561 |
# |
|
|
|
|
|
Evertor muscle activity as a predictor for recurrence in idiopathic clubfoot. |
2560 |
# |
|
|
|
|
|
Evidence for a Dualistic Model of High-grade Serous Carcinoma: BRCA Mutation Status, Histology, and Tubal Intraepithelial Carcinoma. |
2558 |
# |
|
|
|
|
|
Evidence for a peptidoglycan-like structure in Orientia tsutsugamushi. |
2560 |
# |
|
|
|
|
|
Evidence for the efficacy of peginterferon alfa-2a (40 KD) (pegasys) in the treatment of HBeAg-positive chronic hepatitis B (CHB) and impact of baseline factors |
2545 |
# |
|
|
|
|
|
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera |
2564 |
# |
|
|
|
|
|
Evidence of initial success for China exiting COVID-19 social distancing policy after achieving containment |
2563 |
# |
|
|
|
|
|
Evidence suggesting a genetic contribution to kidney stone in northeastern Thai population. |
2552 |
# |
|
|
|
|
|
Evidence supporting the zoonotic and non-zoonotic transmission of Enterocytozoon bieneusi |
2551 |
# |
|
|
|
|
|
Evidence to justify retention of transvaginal mesh: comparison between laparoscopic sacral colpopexy and transvaginal Elevate™ mesh |
2560 |
# |
|
|
|
|
|
Evidence-Based Infectious Diseases: Key Evidence 2004-2005 |
2548 |
# |
|
|
|
|
|
Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association. |
2559 |
# |
|
|
|
|
|
EVOLUTION AMONG O1 HYBRID AND EL TOR VARIANT VIBRIO CHOLERAE O1 STRAINS IN THAILAND |
2562 |
# |
|
|
|
|
|
Evolution of mirror-image pain in temporomandibular joint osteoarthritis mouse model |
2564 |
# |
|
|
|
|
|
Evolution of neurovirulent Zika virus |
2560 |
# |
|
|
|
|
|
Evolution of the complications of laparoscopic hysterectomy after a decade: A follow up of the Monash experience |
2552 |
# |
|
|
|
|
|
Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy |
2561 |
# |
|
|
|
|
|
Evolutionary changes in avian influenza H5N1 viruses in Thailand |
2555 |
# |
|
|
|
|
|
Evolutionary dynamic of antigenic residues on influenza B hemagglutinin. |
2559 |
# |
|
|
|
|
|
Evolutionary dynamic of antigenic residues on influenza B hemagglutinin. |
2560 |
# |
|
|
|
|
|
Ewing Sarcoma in a Patient With Cowden Syndrome |
2558 |
# |
|
|
|
|
|
Ewing's sarcoma and primitive neuroectodermal tumour (ES/PNET) presenting as a breast mass |
2555 |
# |